Lexatumumab
Lexatumumab Basic information
- Product Name:
- Lexatumumab
- Synonyms:
-
- LEXATUMUMAB
- Research Grade Lexatumumab (DHA29105)
- Lexatumumab (anti-TNFRSF10B)
- ETR2-ST01|||DR5 mAB|||HGS-ETR 2
- Research Grade Lexatumumab
- CAS:
- 845816-02-6
- MW:
- 0
- Mol File:
- Mol File
More
Less
Lexatumumab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Lexatumumab Usage And Synthesis
Uses
Treatment of cancer.
in vivo
Lexatumumab (10 mg/kg, i.v., twice a week) increases antitumor effect in vivo when combined with Dacarbazine.html" class="link-product" target="_blank">Dacarbazine (HY-B0078)[2].
| Animal Model: | FEMX-1 xenografts mice[2] |
| Dosage: | 10 mg/kg, 10 mg/kg+Dacarbazine (62.5 mg/kg once a week, i.p. injection) |
| Administration: | i.v., twice a week |
| Result: | Increased antitumor effect in vivo when combined with Dacarbazine (HY-B0078). Induced cleavage of livin into its truncated, proapoptotic form, a compound previously shown to accelerate apoptosis. |
LexatumumabSupplier
Biolab Reagents Gold
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
LGM Pharma
- Tel
- 1-(800)-881-8210
- inquiries@lgmpharma.com
Beijing HuaMeiHuLiBiological Chemical
- Tel
- 010-56205725
- waley188@sohu.com
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com